Current AMD treatment strategies target the growth of new blood vessels (wet AMD) with anti-vascular endothelial growth factor (anti-VEGF) therapies and nutritional approaches focusing on anti-oxidants, to slow the progression of the condition1,3. The gene discussed is VEGFA; the disease is wet macular degeneration.